Atrial Septal Defect Closure With Persistently Elevated Pulmonary Vascular Resistance
Open Access
- 19 June 2026
- journal article
- case report
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (32) , 108916
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia
This publication has 6 references indexed in Scilit:
- 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart DiseaseJACC, 2025
- Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAHEuropean Respiratory Journal, 2022
- Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertensionHeart, 2021
- 2020 ESC Guidelines for the management of adult congenital heart diseaseEuropean Heart Journal, 2020
- “Treat-to-close”: Non-repairable ASD-PAH in the adultInternational Journal of Cardiology, 2019
- Surgical Strategy in Patients with Atrial Septal Defect and Severe Pulmonary HypertensionThe Heart Surgery Forum, 2012